CA2072598A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
CA2072598A1
CA2072598A1 CA002072598A CA2072598A CA2072598A1 CA 2072598 A1 CA2072598 A1 CA 2072598A1 CA 002072598 A CA002072598 A CA 002072598A CA 2072598 A CA2072598 A CA 2072598A CA 2072598 A1 CA2072598 A1 CA 2072598A1
Authority
CA
Canada
Prior art keywords
compound
formula
group
quaternary ammonium
ammonium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002072598A
Other languages
English (en)
French (fr)
Inventor
Richard B. Barlow
Mark A. Veale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2072598A1 publication Critical patent/CA2072598A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002072598A 1990-10-23 1991-10-17 Pharmaceutical compositions Abandoned CA2072598A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9023023.6 1990-10-23
GB909023023A GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA2072598A1 true CA2072598A1 (en) 1992-04-24

Family

ID=10684199

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002072598A Abandoned CA2072598A1 (en) 1990-10-23 1991-10-17 Pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP0506903A1 (de)
JP (1) JPH05504578A (de)
AU (1) AU8714991A (de)
CA (1) CA2072598A1 (de)
FI (1) FI922903A (de)
GB (2) GB9023023D0 (de)
PT (1) PT99299A (de)
WO (1) WO1992006958A1 (de)
ZA (1) ZA918381B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
PE20050231A1 (es) * 2003-06-24 2005-05-20 Novartis Ag Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP3233799B1 (de) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamin-d2-rezeptor-liganden
EP3233077A4 (de) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamin-d2-rezeptor-liganden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792043A (fr) * 1971-11-30 1973-05-29 Ciba Geigy Derives de la piperidine utilisables pour stabiliser des matieres organiques
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici

Also Published As

Publication number Publication date
AU8714991A (en) 1992-05-20
GB9122083D0 (en) 1991-11-27
EP0506903A1 (de) 1992-10-07
WO1992006958A1 (en) 1992-04-30
GB2249093A (en) 1992-04-29
ZA918381B (en) 1993-04-21
GB9023023D0 (en) 1990-12-05
FI922903A0 (fi) 1992-06-22
FI922903A (fi) 1992-06-22
JPH05504578A (ja) 1993-07-15
PT99299A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
DE60129210T2 (de) Zyklische amid-derivate
EP0100200B1 (de) In Stellung 2 substituierte 4-Amino-6,7-dimethoxy-chinoline
BRPI0620386A2 (pt) composição compreendendo a combinação de um antagonista de h3/agonista inverso e um supressor de apetite e uso da referida composição
DE68906816T2 (de) Piperidin- und Piperazinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
PL192397B1 (pl) Pochodna 1-(1,2-dipodstawionej piperydynylo)-4-piperydyny, jej zastosowanie, sposób wytwarzania i kompozycja farmaceutyczna
SK113998A3 (en) 6-phenylpyridyl-2-amine derivatives
CN101605784A (zh) 氮杂桥环化合物
IE73873B1 (en) Heterocyclic compounds and their preparation and use
US10106522B2 (en) Benzimidazole derivatives as antihistamine agents
RU2188197C2 (ru) 1,4-дизамещенные пиперазины, способ их получения, фармацевтическая композиция и способ лечения нейрогенного воспаления
CA2072598A1 (en) Pharmaceutical compositions
BG98068A (bg) Съединение с формула 4-(/2-бензотиазолил/метиламино)-алфа- (/3,4-дифлуорофенокси/метил)-1-пиперидинетанол, методи за получаване и използуването му, както и фармацевтични състави с това съединение и методи за тяхното получаване
DE69523595T2 (de) Aryl und heteroaryl alkoxynaphtalen derivate
KR100437561B1 (ko) 신규헤테로고리화합물
JPS62129271A (ja) ピリジン化合物およびその製法
WO1993007122A1 (en) 4-diphenylacetoxy-n-substituted piperidines with antimuscarinic activity
JPWO2006030931A1 (ja) Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
US4716166A (en) Histamine H1 antagonists
US6949656B2 (en) Cyclic amine derivatives and use thereof
EP0451772A1 (de) Piperidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
JPH0741481A (ja) 両性型三環系化合物
US4309544A (en) Preparation of 6-oxa-1-azatricyclo(6.2.2.02,7)dodecane-5-ones
EP0707579B1 (de) Piperidinyl-substituierte methanoanthracene als d1/d2-antagonisten und 5ht2-serotonin-antagonisten
EP0785195A1 (de) Piperidin- oder Tetrahydropyridin-Derivate mit Serotonin 5-HTIA-Rezeptor-Affinität
JPS59501318A (ja) ヘテロアリ−ル置換アミノメチルベンゼン誘導体

Legal Events

Date Code Title Description
FZDE Dead